Table of Content

1 Norovirus Vaccine Market Overview
1.1 Product Overview and Scope of Norovirus Vaccine
1.2 Norovirus Vaccine Segment by Type
1.2.1 Global Norovirus Vaccine Market Value Comparison by Type (2024-2034)
1.2.2 Bivalent
1.2.3 Quadrivalent
1.2.4 Hexavalent
1.3 Norovirus Vaccine Segment by Application
1.3.1 Global Norovirus Vaccine Market Value by Application: (2024-2034)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Norovirus Vaccine Market Size Estimates and Forecasts
1.4.1 Global Norovirus Vaccine Revenue 2018-2029
1.4.2 Global Norovirus Vaccine Sales 2018-2029
1.4.3 Global Norovirus Vaccine Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Norovirus Vaccine Market Competition by Manufacturers
2.1 Global Norovirus Vaccine Sales Market Share by Manufacturers (2018-2024)
2.2 Global Norovirus Vaccine Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Norovirus Vaccine Average Price by Manufacturers (2018-2024)
2.4 Global Norovirus Vaccine Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Norovirus Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Norovirus Vaccine, Product Type & Application
2.7 Norovirus Vaccine Market Competitive Situation and Trends
2.7.1 Norovirus Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Norovirus Vaccine Players Market Share by Revenue
2.7.3 Global Norovirus Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Norovirus Vaccine Retrospective Market Scenario by Region
3.1 Global Norovirus Vaccine Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Norovirus Vaccine Global Norovirus Vaccine Sales by Region: 2018-2029
3.2.1 Global Norovirus Vaccine Sales by Region: 2018-2024
3.2.2 Global Norovirus Vaccine Sales by Region: 2024-2029
3.3 Global Norovirus Vaccine Global Norovirus Vaccine Revenue by Region: 2018-2029
3.3.1 Global Norovirus Vaccine Revenue by Region: 2018-2024
3.3.2 Global Norovirus Vaccine Revenue by Region: 2024-2029
3.4 North America Norovirus Vaccine Market Facts & Figures by Country
3.4.1 North America Norovirus Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Norovirus Vaccine Sales by Country (2018-2029)
3.4.3 North America Norovirus Vaccine Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Norovirus Vaccine Market Facts & Figures by Country
3.5.1 Europe Norovirus Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Norovirus Vaccine Sales by Country (2018-2029)
3.5.3 Europe Norovirus Vaccine Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Norovirus Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific Norovirus Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Norovirus Vaccine Sales by Country (2018-2029)
3.6.3 Asia Pacific Norovirus Vaccine Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Norovirus Vaccine Market Facts & Figures by Country
3.7.1 Latin America Norovirus Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Norovirus Vaccine Sales by Country (2018-2029)
3.7.3 Latin America Norovirus Vaccine Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Norovirus Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Norovirus Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Norovirus Vaccine Sales by Country (2018-2029)
3.8.3 Middle East and Africa Norovirus Vaccine Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Norovirus Vaccine Sales by Type (2018-2029)
4.1.1 Global Norovirus Vaccine Sales by Type (2018-2024)
4.1.2 Global Norovirus Vaccine Sales by Type (2024-2029)
4.1.3 Global Norovirus Vaccine Sales Market Share by Type (2018-2029)
4.2 Global Norovirus Vaccine Revenue by Type (2018-2029)
4.2.1 Global Norovirus Vaccine Revenue by Type (2018-2024)
4.2.2 Global Norovirus Vaccine Revenue by Type (2024-2029)
4.2.3 Global Norovirus Vaccine Revenue Market Share by Type (2018-2029)
4.3 Global Norovirus Vaccine Price by Type (2018-2029)
5 Segment by Application
5.1 Global Norovirus Vaccine Sales by Application (2018-2029)
5.1.1 Global Norovirus Vaccine Sales by Application (2018-2024)
5.1.2 Global Norovirus Vaccine Sales by Application (2024-2029)
5.1.3 Global Norovirus Vaccine Sales Market Share by Application (2018-2029)
5.2 Global Norovirus Vaccine Revenue by Application (2018-2029)
5.2.1 Global Norovirus Vaccine Revenue by Application (2018-2024)
5.2.2 Global Norovirus Vaccine Revenue by Application (2024-2029)
5.2.3 Global Norovirus Vaccine Revenue Market Share by Application (2018-2029)
5.3 Global Norovirus Vaccine Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Hillevax
6.1.1 Hillevax Corporation Information
6.1.2 Hillevax Description and Business Overview
6.1.3 Hillevax Norovirus Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.1.4 Hillevax Norovirus Vaccine Product Portfolio
6.1.5 Hillevax Recent Developments/Updates
6.2 Vaxart
6.2.1 Vaxart Corporation Information
6.2.2 Vaxart Description and Business Overview
6.2.3 Vaxart Norovirus Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.2.4 Vaxart Norovirus Vaccine Product Portfolio
6.2.5 Vaxart Recent Developments/Updates
6.3 Moderna
6.3.1 Moderna Corporation Information
6.3.2 Moderna Description and Business Overview
6.3.3 Moderna Norovirus Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.3.4 Moderna Norovirus Vaccine Product Portfolio
6.3.5 Moderna Recent Developments/Updates
6.4 UMN Pharma
6.4.1 UMN Pharma Corporation Information
6.4.2 UMN Pharma Description and Business Overview
6.4.3 UMN Pharma Norovirus Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.4.4 UMN Pharma Norovirus Vaccine Product Portfolio
6.4.5 UMN Pharma Recent Developments/Updates
6.5 Daiichi Sankyo
6.5.1 Daiichi Sankyo Corporation Information
6.5.2 Daiichi Sankyo Description and Business Overview
6.5.3 Daiichi Sankyo Norovirus Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.5.4 Daiichi Sankyo Norovirus Vaccine Product Portfolio
6.5.5 Daiichi Sankyo Recent Developments/Updates
6.6 Kanghua Biology
6.6.1 Kanghua Biology Corporation Information
6.6.2 Kanghua Biology Description and Business Overview
6.6.3 Kanghua Biology Norovirus Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.6.4 Kanghua Biology Norovirus Vaccine Product Portfolio
6.6.5 Kanghua Biology Recent Developments/Updates
6.7 Beijing Institute of Biological Products
6.6.1 Beijing Institute of Biological Products Corporation Information
6.6.2 Beijing Institute of Biological Products Description and Business Overview
6.6.3 Beijing Institute of Biological Products Norovirus Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Beijing Institute of Biological Products Norovirus Vaccine Product Portfolio
6.7.5 Beijing Institute of Biological Products Recent Developments/Updates
6.8 Zhifei Bio
6.8.1 Zhifei Bio Corporation Information
6.8.2 Zhifei Bio Description and Business Overview
6.8.3 Zhifei Bio Norovirus Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.8.4 Zhifei Bio Norovirus Vaccine Product Portfolio
6.8.5 Zhifei Bio Recent Developments/Updates
6.9 China Biotechnology Co., Ltd.
6.9.1 China Biotechnology Co., Ltd. Corporation Information
6.9.2 China Biotechnology Co., Ltd. Description and Business Overview
6.9.3 China Biotechnology Co., Ltd. Norovirus Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.9.4 China Biotechnology Co., Ltd. Norovirus Vaccine Product Portfolio
6.9.5 China Biotechnology Co., Ltd. Recent Developments/Updates
6.10 North China Pharmaceutical
6.10.1 North China Pharmaceutical Corporation Information
6.10.2 North China Pharmaceutical Description and Business Overview
6.10.3 North China Pharmaceutical Norovirus Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.10.4 North China Pharmaceutical Norovirus Vaccine Product Portfolio
6.10.5 North China Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Norovirus Vaccine Industry Chain Analysis
7.2 Norovirus Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Norovirus Vaccine Production Mode & Process
7.4 Norovirus Vaccine Sales and Marketing
7.4.1 Norovirus Vaccine Sales Channels
7.4.2 Norovirus Vaccine Distributors
7.5 Norovirus Vaccine Customers
8 Norovirus Vaccine Market Dynamics
8.1 Norovirus Vaccine Industry Trends
8.2 Norovirus Vaccine Market Drivers
8.3 Norovirus Vaccine Market Challenges
8.4 Norovirus Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Norovirus Vaccine Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Norovirus Vaccine Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Norovirus Vaccine Market Competitive Situation by Manufacturers in 2022
Table 4. Global Norovirus Vaccine Sales (K Units) of Key Manufacturers (2018-2024)
Table 5. Global Norovirus Vaccine Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Norovirus Vaccine Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Norovirus Vaccine Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Norovirus Vaccine Average Price (US$/Unit) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Norovirus Vaccine, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Norovirus Vaccine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Norovirus Vaccine, Product Type & Application
Table 12. Global Key Manufacturers of Norovirus Vaccine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Norovirus Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Norovirus Vaccine as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Norovirus Vaccine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Norovirus Vaccine Sales by Region (2018-2024) & (K Units)
Table 18. Global Norovirus Vaccine Sales Market Share by Region (2018-2024)
Table 19. Global Norovirus Vaccine Sales by Region (2024-2029) & (K Units)
Table 20. Global Norovirus Vaccine Sales Market Share by Region (2024-2029)
Table 21. Global Norovirus Vaccine Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Norovirus Vaccine Revenue Market Share by Region (2018-2024)
Table 23. Global Norovirus Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Norovirus Vaccine Revenue Market Share by Region (2024-2029)
Table 25. North America Norovirus Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Norovirus Vaccine Sales by Country (2018-2024) & (K Units)
Table 27. North America Norovirus Vaccine Sales by Country (2024-2029) & (K Units)
Table 28. North America Norovirus Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Norovirus Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Norovirus Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Norovirus Vaccine Sales by Country (2018-2024) & (K Units)
Table 32. Europe Norovirus Vaccine Sales by Country (2024-2029) & (K Units)
Table 33. Europe Norovirus Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Norovirus Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Norovirus Vaccine Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Norovirus Vaccine Sales by Region (2018-2024) & (K Units)
Table 37. Asia Pacific Norovirus Vaccine Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Norovirus Vaccine Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Norovirus Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Norovirus Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Norovirus Vaccine Sales by Country (2018-2024) & (K Units)
Table 42. Latin America Norovirus Vaccine Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Norovirus Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Norovirus Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Norovirus Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Norovirus Vaccine Sales by Country (2018-2024) & (K Units)
Table 47. Middle East & Africa Norovirus Vaccine Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Norovirus Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Norovirus Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Norovirus Vaccine Sales (K Units) by Type (2018-2024)
Table 51. Global Norovirus Vaccine Sales (K Units) by Type (2024-2029)
Table 52. Global Norovirus Vaccine Sales Market Share by Type (2018-2024)
Table 53. Global Norovirus Vaccine Sales Market Share by Type (2024-2029)
Table 54. Global Norovirus Vaccine Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Norovirus Vaccine Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Norovirus Vaccine Revenue Market Share by Type (2018-2024)
Table 57. Global Norovirus Vaccine Revenue Market Share by Type (2024-2029)
Table 58. Global Norovirus Vaccine Price (US$/Unit) by Type (2018-2024)
Table 59. Global Norovirus Vaccine Price (US$/Unit) by Type (2024-2029)
Table 60. Global Norovirus Vaccine Sales (K Units) by Application (2018-2024)
Table 61. Global Norovirus Vaccine Sales (K Units) by Application (2024-2029)
Table 62. Global Norovirus Vaccine Sales Market Share by Application (2018-2024)
Table 63. Global Norovirus Vaccine Sales Market Share by Application (2024-2029)
Table 64. Global Norovirus Vaccine Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Norovirus Vaccine Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Norovirus Vaccine Revenue Market Share by Application (2018-2024)
Table 67. Global Norovirus Vaccine Revenue Market Share by Application (2024-2029)
Table 68. Global Norovirus Vaccine Price (US$/Unit) by Application (2018-2024)
Table 69. Global Norovirus Vaccine Price (US$/Unit) by Application (2024-2029)
Table 70. Hillevax Corporation Information
Table 71. Hillevax Description and Business Overview
Table 72. Hillevax Norovirus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 73. Hillevax Norovirus Vaccine Product
Table 74. Hillevax Recent Developments/Updates
Table 75. Vaxart Corporation Information
Table 76. Vaxart Description and Business Overview
Table 77. Vaxart Norovirus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 78. Vaxart Norovirus Vaccine Product
Table 79. Vaxart Recent Developments/Updates
Table 80. Moderna Corporation Information
Table 81. Moderna Description and Business Overview
Table 82. Moderna Norovirus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 83. Moderna Norovirus Vaccine Product
Table 84. Moderna Recent Developments/Updates
Table 85. UMN Pharma Corporation Information
Table 86. UMN Pharma Description and Business Overview
Table 87. UMN Pharma Norovirus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 88. UMN Pharma Norovirus Vaccine Product
Table 89. UMN Pharma Recent Developments/Updates
Table 90. Daiichi Sankyo Corporation Information
Table 91. Daiichi Sankyo Description and Business Overview
Table 92. Daiichi Sankyo Norovirus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 93. Daiichi Sankyo Norovirus Vaccine Product
Table 94. Daiichi Sankyo Recent Developments/Updates
Table 95. Kanghua Biology Corporation Information
Table 96. Kanghua Biology Description and Business Overview
Table 97. Kanghua Biology Norovirus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 98. Kanghua Biology Norovirus Vaccine Product
Table 99. Kanghua Biology Recent Developments/Updates
Table 100. Beijing Institute of Biological Products Corporation Information
Table 101. Beijing Institute of Biological Products Description and Business Overview
Table 102. Beijing Institute of Biological Products Norovirus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 103. Beijing Institute of Biological Products Norovirus Vaccine Product
Table 104. Beijing Institute of Biological Products Recent Developments/Updates
Table 105. Zhifei Bio Corporation Information
Table 106. Zhifei Bio Description and Business Overview
Table 107. Zhifei Bio Norovirus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 108. Zhifei Bio Norovirus Vaccine Product
Table 109. Zhifei Bio Recent Developments/Updates
Table 110. China Biotechnology Co., Ltd. Corporation Information
Table 111. China Biotechnology Co., Ltd. Description and Business Overview
Table 112. China Biotechnology Co., Ltd. Norovirus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 113. China Biotechnology Co., Ltd. Norovirus Vaccine Product
Table 114. China Biotechnology Co., Ltd. Recent Developments/Updates
Table 115. North China Pharmaceutical Corporation Information
Table 116. North China Pharmaceutical Description and Business Overview
Table 117. North China Pharmaceutical Norovirus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 118. North China Pharmaceutical Norovirus Vaccine Product
Table 119. North China Pharmaceutical Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Norovirus Vaccine Distributors List
Table 123. Norovirus Vaccine Customers List
Table 124. Norovirus Vaccine Market Trends
Table 125. Norovirus Vaccine Market Drivers
Table 126. Norovirus Vaccine Market Challenges
Table 127. Norovirus Vaccine Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Norovirus Vaccine
Figure 2. Global Norovirus Vaccine Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Norovirus Vaccine Market Share by Type in 2022 & 2029
Figure 4. Bivalent Product Picture
Figure 5. Quadrivalent Product Picture
Figure 6. Hexavalent Product Picture
Figure 7. Global Norovirus Vaccine Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 8. Global Norovirus Vaccine Market Share by Application in 2022 & 2029
Figure 9. Hospital
Figure 10. Clinic
Figure 11. Others
Figure 12. Global Norovirus Vaccine Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Norovirus Vaccine Market Size (2018-2029) & (US$ Million)
Figure 14. Global Norovirus Vaccine Sales (2018-2029) & (K Units)
Figure 15. Global Norovirus Vaccine Average Price (US$/Unit) & (2018-2029)
Figure 16. Norovirus Vaccine Report Years Considered
Figure 17. Norovirus Vaccine Sales Share by Manufacturers in 2022
Figure 18. Global Norovirus Vaccine Revenue Share by Manufacturers in 2022
Figure 19. The Global 5 and 10 Largest Norovirus Vaccine Players: Market Share by Revenue in 2022
Figure 20. Norovirus Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 21. Global Norovirus Vaccine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 22. North America Norovirus Vaccine Sales Market Share by Country (2018-2029)
Figure 23. North America Norovirus Vaccine Revenue Market Share by Country (2018-2029)
Figure 24. United States Norovirus Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Canada Norovirus Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 26. Europe Norovirus Vaccine Sales Market Share by Country (2018-2029)
Figure 27. Europe Norovirus Vaccine Revenue Market Share by Country (2018-2029)
Figure 28. Germany Norovirus Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. France Norovirus Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. U.K. Norovirus Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Italy Norovirus Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Russia Norovirus Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Asia Pacific Norovirus Vaccine Sales Market Share by Region (2018-2029)
Figure 34. Asia Pacific Norovirus Vaccine Revenue Market Share by Region (2018-2029)
Figure 35. China Norovirus Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. Japan Norovirus Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. South Korea Norovirus Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. India Norovirus Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Australia Norovirus Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. China Taiwan Norovirus Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Southeast Asia Norovirus Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Latin America Norovirus Vaccine Sales Market Share by Country (2018-2029)
Figure 43. Latin America Norovirus Vaccine Revenue Market Share by Country (2018-2029)
Figure 44. Mexico Norovirus Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Brazil Norovirus Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Argentina Norovirus Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Colombia Norovirus Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Middle East & Africa Norovirus Vaccine Sales Market Share by Country (2018-2029)
Figure 49. Middle East & Africa Norovirus Vaccine Revenue Market Share by Country (2018-2029)
Figure 50. Turkey Norovirus Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Saudi Arabia Norovirus Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. UAE Norovirus Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Global Sales Market Share of Norovirus Vaccine by Type (2018-2029)
Figure 54. Global Revenue Market Share of Norovirus Vaccine by Type (2018-2029)
Figure 55. Global Norovirus Vaccine Price (US$/Unit) by Type (2018-2029)
Figure 56. Global Sales Market Share of Norovirus Vaccine by Application (2018-2029)
Figure 57. Global Revenue Market Share of Norovirus Vaccine by Application (2018-2029)
Figure 58. Global Norovirus Vaccine Price (US$/Unit) by Application (2018-2029)
Figure 59. Norovirus Vaccine Value Chain
Figure 60. Norovirus Vaccine Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed